alluvi-peptides215107 - Profile

About me

Profile

Alluvi, known as BI 4744, represents a significant breakthrough in obesity care. This dual stimulator targeting both GLP-1 and GIP receptors demonstrates impressive results in research studies,

https://alluvi-research.co.uk/product/alluvi-retatrutide-40mg-rd-only/